Balanced Activation of Striatal Output Pathways by Faster Off-Rate Phosphodiesterase 10A Inhibitors Potentially Leads to not only Antipsychotic-Like Effects but also Activation of the Prefrontal Cortex and Cognitive Improvement in Rodents

Haruhide KIMURA

講演情報

[AsCNP] シンポジウム

AsCNP » [AsCNP] シンポジウム

[AsCNP_S40] シンポジウム40
Noteworthy drug discovery/research and development - Aiming for innovation -

2019年10月13日(日) 08:40 〜 10:20 第1会場 (メインホール)

Organizer / Chair: Tetsurou KIKUCHI (New Drug Research Division, Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd.), Co-chair: George KOOB (National Institute on Alcohol Abuse and Alcoholism, USA)

08:50 〜 08:59

[AsCNP-S40-2] Balanced Activation of Striatal Output Pathways by Faster Off-Rate Phosphodiesterase 10A Inhibitors Potentially Leads to not only Antipsychotic-Like Effects but also Activation of the Prefrontal Cortex and Cognitive Improvement in Rodents

^○Haruhide KIMURA (Neuroscience Drug Discovery Unit, Research, Takeda Parmaceutical Company Limited)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードは事前参加登録者へメール、および参加証に印字してお送りします。プログラム抄録集の「大会参加者へのご案内」にも掲載しております。

講演情報

[AsCNP_S40] シンポジウム40Noteworthy drug discovery/research and development - Aiming for innovation -

[AsCNP-S40-2] Balanced Activation of Striatal Output Pathways by Faster Off-Rate Phosphodiesterase 10A Inhibitors Potentially Leads to not only Antipsychotic-Like Effects but also Activation of the Prefrontal Cortex and Cognitive Improvement in Rodents

パスワード

[AsCNP_S40] シンポジウム40
Noteworthy drug discovery/research and development - Aiming for innovation -